- Home
- HBB vs DRTS Comparison
HBB vs DRTS Comparison
Compare HBB & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBB
- DRTS
- Stock Information
- Founded
- HBB 1904
- DRTS 2015
- Country
- HBB United States
- DRTS Israel
- Employees
- HBB N/A
- DRTS N/A
- Industry
- HBB Home Furnishings
- DRTS Medical/Dental Instruments
- Sector
- HBB Consumer Discretionary
- DRTS Health Care
- Exchange
- HBB Nasdaq
- DRTS Nasdaq
- Market Cap
- HBB 247.5M
- DRTS 211.7M
- IPO Year
- HBB 2017
- DRTS N/A
- Fundamental
- Price
- HBB $14.52
- DRTS $2.95
- Analyst Decision
- HBB
- DRTS Strong Buy
- Analyst Count
- HBB 0
- DRTS 2
- Target Price
- HBB N/A
- DRTS $8.00
- AVG Volume (30 Days)
- HBB 70.2K
- DRTS 27.4K
- Earning Date
- HBB 04-30-2025
- DRTS 05-19-2025
- Dividend Yield
- HBB 3.21%
- DRTS N/A
- EPS Growth
- HBB 18.18
- DRTS N/A
- EPS
- HBB 2.43
- DRTS N/A
- Revenue
- HBB $659,788,000.00
- DRTS N/A
- Revenue This Year
- HBB N/A
- DRTS N/A
- Revenue Next Year
- HBB N/A
- DRTS N/A
- P/E Ratio
- HBB $6.01
- DRTS N/A
- Revenue Growth
- HBB 5.46
- DRTS N/A
- 52 Week Low
- HBB $13.25
- DRTS $1.75
- 52 Week High
- HBB $31.78
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- HBB 33.37
- DRTS 68.40
- Support Level
- HBB $13.68
- DRTS $2.50
- Resistance Level
- HBB $20.14
- DRTS $2.96
- Average True Range (ATR)
- HBB 1.24
- DRTS 0.15
- MACD
- HBB -0.43
- DRTS 0.04
- Stochastic Oscillator
- HBB 16.96
- DRTS 97.83
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.